Harms associated with taking nalmefene for substance use and impulse control disorders: A systematic review and meta-analysis of randomised controlled trials

IMPORTANCE: Nalmefene is a newly approved drug for alcohol use disorder, but the risk of harms has not been evaluated from empirical trial evidence. OBJECTIVE: To assess the harm of nalmefene administered to individuals diagnosed with substance use or impulse control disorders by performing a system...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansen, Karina Glies Vincents, Tarp, Simon, Astrup, Arne, Lund, Hans, Pagsberg, Anne K., Christensen, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574613/
https://www.ncbi.nlm.nih.gov/pubmed/28850596
http://dx.doi.org/10.1371/journal.pone.0183821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574613/
https://www.ncbi.nlm.nih.gov/pubmed/28850596
http://dx.doi.org/10.1371/journal.pone.0183821

Ejemplares similares